Brian Blaser
Brian J. Blaser, with 25+ years in in-vitro diagnostics, is appointed CEO of QuidelOrtho to drive strategy and improve operating income.
Blaser's tenure at Abbott included launching the Alinity instruments and acquiring Alere, solidifying Abbott's leadership in rapid diagnostics.
Former colleagues praise Blaser's integrity and operational skills but note his lack of strategic vision and tendency to micromanage.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.